Treatment of Keloidscars With Intralesional Triamcinolone and 5-fluorouracil Injections-prospective, Randomized, Controlled Trial - Pilot Study

Tampere University Hospital

Status and phase: Completed; Phase 4

Conditions: Keloidscars

Treatments: Drug: 5-fluorouracil; Drug: Triamcinolone

Study type: Interventional

Funder types: Other

Identifiers

NCT02155439

140260M

2013-004512-22 (EudraCT Number)

Details and patient eligibility

About

The aim of study is examine the efficacy of intralesional 5-fluorouracil injections in keloid disease treatment.

Enrollment: 50 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Person who has a keloidscar which could be treated with injection treatment

Exclusion criteria

• Pregnancy, lactating, renal or liver failure

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

50 participants in 2 patient groups

Triamcinolone

Active Comparator group

Description:

kortikosteroid

Treatment:

Drug: 5-fluorouracil

5-fluorouracil

Active Comparator group

Description:

antimitotic drug

Treatment:

Drug: Triamcinolone